Table 4

GSRS and GIQLI scores by physician's rating of clinical disease severity at baseline


Groups by rating of clinical severity
Kruskall-Wallis
Test of overall differences

Patient reported outcome
instrument and domain
None (n = 20)
mean (SD)
Mild (n = 6)
mean (SD)
Moderate (n = 32)
mean (SD)
Severe (n = 4)
mean (SD)
Chi-Square
p-value
Wilcoxon
rank-sum tests
(pairwise
comparisons
with p < 0.001)

GSRS Abdominal Pain
1.33 (0.42)
2.61 (0.93)
3.29 (1.23)
3.83 (1.69)
33.75
<0.001
b
GSRS Reflux Syndrome
1.10 (0.26)
2.42 (1.32)
3.09 (1.46)
4.00 (2.12)
29.25
<0.001
b, c
GSRS Diarrhea
1.12 (0.20)
3.61 (1.69)
3.57 (1.56)
2.67 (1.70)
37.21
<0.001
a, b
GSRS Indigestion Syndrome
1.29 (0.33)
3.29 (1.81)
3.76 (1.43)
4.81 (1.68)
38.29
<0.001
a, b
GSRS Constipation
1.20 (0.38)
1.94 (0.65)
2.55 (1.26)
3.42 (2.23)
27.03
<0.001
b








GIQLI Total Score
126.00 (10.97)
95.83 (23.22)
87.02 (22.08)
65.00 (37.37)
33.25
<0.001
b
GIQLI Symptoms
3.64 (0.30)
2.65 (0.68)
2.49 (0.57)
1.87 (0.82)
35.31
<0.001
b
GIQLI Emotion
3.24 (0.64)
2.87 (0.70)
2.47 (0.74)
1.60 (0.86)
16.33
<0.001

GIQLI Physical Function
3.21 (0.61)
2.14 (0.89)
1.92 (0.91)
1.61 (1.62)
22.00
<0.001
b
GIQLI Social Function
3.55 (0.60)
3.04 (0.70)
2.74 (0.96)
2.19 (1.60)
10.22
0.017

GIQLI Medical Treatment
3.95 (0.22)
4.00 (0.00)
2.94 (1.11)
1.50 (1.91)
21.25
<0.001
b, c

Comparisons not significant unless noted.

a = none vs. mild; b = none vs. moderate; c = none vs. severe;

d = mild vs. moderate; e = mild vs. severe; f = moderate vs. severe.

Machnicki et al. Health and Quality of Life Outcomes 2008 6:53   doi:10.1186/1477-7525-6-53